Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates the immune system in some patients with metastatic non-small-cell lung cancer, increasing progression-free survival.

26 Sep 2019

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.

26 Sep 2019

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

A secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men and calls for rethinking treatment guidelines based on a patient's post-operative prostate-specific antigen (PSA) level.

26 Sep 2019

Closure of women's health clinics linked to lower cervical cancer screening and higher mortality

Following the closure of nearly 100 women's health clinics across the United States from 2010 to 2013, fewer women were screened for cervical cancer, more women were diagnosed with advanced stages of the disease and mortality rates rose.

26 Sep 2019

Personal Genome Diagnostics applies CE mark to PGDx elio tissue complete assay

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced that it has applied the CE mark to the PGDx elio™ tissue complete assay.

26 Sep 2019

Eisai and Fronteo announce launch of Coroban to predict inpatients' tumbling and falling risks

Eisai Co., Ltd. and FRONTEO, Inc. announced today that they have launched the tumbling and falling prediction system Coroban to medical institutions in Japan on September 26, 2019. The Coroban predicts inpatients' tumbling and falling risks in advance and displays alerts.

26 Sep 2019

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer (NSCLC) and kidney cancer.

26 Sep 2019

Late-breaking TAILORx data to be presented at ESMO Congress 2019

New data from TAILORx, the federally funded, phase three clinical trial, will be presented as late-breaking information at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain.

26 Sep 2019

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.

25 Sep 2019

Study receives $3.1 million NIH grant to improve quality of life for African American cancer survivors

African Americans have the lowest survival rate of any racial or ethnic group in the United States for most cancers - a problem that is magnificent in southeast Michigan.

25 Sep 2019

Johns Hopkins researchers link a gene to melanoma growth and spread

Using a small noncoding RNA, microRNA 211, and tools that track the stability and decay of the protein-coding and noncoding RNAs in lab-grown melanoma cells, a team led by a Johns Hopkins Kimmel Cancer Center researcher identified highly unstable RNA molecules in human melanomas, including a novel miR-211 target gene DUSP3.

From Johns Hopkins Medicine 25 Sep 2019

Targeting cancer patients' mindsets could improve their health and well-being

A diagnosis of cancer can cause significant emotional burden for patients and their families. The turmoil may persist throughout treatment and even years into survivorship.

25 Sep 2019

MR Solutions’ new liquid helium-free PET-MR system to be displayed at WMIC

MR Solutions’ latest liquid helium free PET-MR preclinical imaging system for the molecular research community was the subject of talks and papers on simultaneous PET-MR imaging at the World Molecular Imaging Congress held in Montreal in September.

From MR Solutions 25 Sep 2019

Oncologists respond quickly to emerging FDA safety data for drugs, study finds

Within six months of the U.S. Food and Drug Administration's move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.

24 Sep 2019

Researchers explore risk of ALL in children with Down syndrome

Acute lymphoblastic leukemia (ALL), is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL than children without Down syndrome.

24 Sep 2019

Research: Protein complex represents a new metabolic target for liver cancer

Disrupting a metabolic pathway in the liver in a way that creates a more "cancer-like" metabolism actually reduces tumor formation in a mouse model of liver cancer.

24 Sep 2019

Wake Forest Baptist receives multimillion-dollar grant for innovative cancer care research

For the second time in five years, Wake Forest Baptist Health has been recognized for its expertise in conducting innovative cancer care research by the National Cancer Institute's Community Oncology Research Program with a multimillion-dollar grant.

23 Sep 2019

Version of an antibiotic drug extends survival in mice with lethal pediatric brain tumors

Versions of an antibiotic drug called DON first isolated from soil bacteria more than 60 years ago have shown promising signs of extending survival in mice models of especially lethal pediatric brain tumors marked by the high expression of a cancer-causing gene known as the MYC oncogene, according to results of two studies from researchers at the Johns Hopkins Kimmel Cancer Center.

23 Sep 2019

U-M and Karmanos receive NCI grant to find new solutions for prostate cancer

Michigan's two elite cancer programs are joining forces to find new solutions for prostate cancer. The University of Michigan Rogel Cancer and the Barbara Ann Karmanos Cancer Institute have received a prestigious $9.2 million grant from the National Cancer Institute.

23 Sep 2019

UCSF launches new initiative to accelerate prostate cancer research

UC San Francisco announced Thursday it will establish the UCSF Benioff Initiative for Prostate Cancer Research, made possible by a $35 million gift from Marc and Lynne Benioff.

23 Sep 2019

Oncology News and Research

Further Reading

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

Closure of women's health clinics linked to lower cervical cancer screening and higher mortality

Personal Genome Diagnostics applies CE mark to PGDx elio tissue complete assay

Eisai and Fronteo announce launch of Coroban to predict inpatients' tumbling and falling risks

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Late-breaking TAILORx data to be presented at ESMO Congress 2019

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

Study receives $3.1 million NIH grant to improve quality of life for African American cancer survivors

Johns Hopkins researchers link a gene to melanoma growth and spread

Targeting cancer patients' mindsets could improve their health and well-being

MR Solutions’ new liquid helium-free PET-MR system to be displayed at WMIC

Oncologists respond quickly to emerging FDA safety data for drugs, study finds

Researchers explore risk of ALL in children with Down syndrome

Research: Protein complex represents a new metabolic target for liver cancer

Wake Forest Baptist receives multimillion-dollar grant for innovative cancer care research

Version of an antibiotic drug extends survival in mice with lethal pediatric brain tumors

U-M and Karmanos receive NCI grant to find new solutions for prostate cancer

UCSF launches new initiative to accelerate prostate cancer research

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News